Steve Lisi

CEO and Chairman of the Board

Steve Lisi has served on our Board since January 2017. Mr. Lisi was previously Senior Vice President of Business and Corporate Development at Avadel Pharmaceuticals (AVDL) where he was instrumental in restructuring the company, raising over $125M, and transforming it from a $100 million enterprise value to $1 billion in three years. Prior to his position at Avadel, Mr. Lisi spent 18 years investing in the global healthcare industry at Deerfield Management, Millennium Management, and SAC Capital, amongst others. Mr. Lisi serves as Chairman of the Board of Beyond Cancer, a nitric oxide based immuno-oncology company targeting solid tumors. He received his master’s degree in International Business from Pepperdine University.  

Amir Avniel

President & Chief Business Officer

Amir Avniel is the President & Chief Business Officer, and co-founder of Beyond Air. He has over 20 years of experience leading biotechnology companies. Prior to Beyond Air, he co-founded Rosetta Green, which was eventually acquired by Monsanto. Prior to Rosetta Green, he served as the president and the Chief Executive Officer of Rosetta Genomics, a NASDAQ company. He studied computer science at the Academic College of Tel Aviv – Jaffa Israel and earned a bachelor’s degree in Social Sciences and Humanities from Open University in Israel. Prior to his academic studies, he served as an officer in the Israel Defense Force, where he was awarded four commendations for excellence.

Duncan Fatkin

Chief Commercial Officer

Duncan Fatkin joined Beyond Air as its Chief Commercial Officer in January 2019. Mr. Fatkin has a successful track record in the global medical device and biopharmaceutical industries, building out commercial capabilities, leading marketing and sales teams, and cultivating strong thought leader relationships across multiple specialties. His 30 years of experience includes, most recently, roles with Becton Dickinson (Worldwide Vice President, Injection, Diabetes Care), Zimmer Biomet (Vice President and General Manager, Office Based Technologies), Smith & Nephew/Bioventus (Vice President, Global Marketing & Reimbursement) and DePuy/Johnson & Johnson (Worldwide Vice President, iOrthopaedics). Mr. Fatkin has spent more than 10 years of his career in both Europe and the Asia Pacific region, with the last 12+ years in the United States. He received his Bachelor of Arts degree in Materials Science from Oxford University and his Diploma in Marketing from the University of West London.

Douglas Larson

Chief Financial Officer

Douglas Larson joined Beyond Air as its Chief Financial Officer in September 2021 with over 20 years of international and operational financial leadership experience. Most recently, he was an independent consultant providing operational and financial consulting services from February 2021 until August 2021.  Prior to that, Mr. Larson served as Vice President, Finance and Head of Global Controlling at DBV Technologies, Inc. (NASDAQ: DBVT), a global clinical stage biopharmaceutical company headquartered in France, from 2017 to 2020. Previously, Mr. Larson served as the Chief Financial Officer of The Scotts Miracle-Gro Company’s International division, based in Lyon, France from 2001 to 2015.  Mr. Larson graduated from the Certified General Accountant’s Association of Canada in 2001 and HEC Paris’ Executive MBA program in 2015.

Frederick Montgomery, PhD

Vice President of Medical Systems

Fred Montgomery has spent the last 28 years developing and patenting NO delivery system technology leading to the commercialization of nitric oxide therapy. He led the development of the INOvent delivery system for Datex-Ohmeda, which in 2000 was the first FDA 510(k) cleared nitric oxide delivery system that led to the commercial marketing of INO Therapy in the year 2000. He established the Medical Device Group at INO Therapeutics which developed the INOmax DS and DSIR products, the leading NO delivery systems in the United States to this day. Mr. Montgomery left Ikaria (formerly INO Therapeutics) in 2011 and co-founded NitricGen Inc. He received his Doctor of Philosophy degree from the University of Salford, England and his Master’s of Business Administration from the University of Bradford, England.

Michael Gaul

Chief Operating Officer

Michael Gaul is Beyond Air's Chief Operating Officer. Mr. Gaul has a proven track record in multiple Industries that include: Medical Devices and Reagents, Semiconductor Automation Capital Equipment, Public Safety Communication Systems, and Complex Industrial Controls and Instrumentation. He has led teams in operations, sales and marketing, supply chain, distribution, quality, regulatory, human resources, and finance. He has had P&L experience with multi-plant responsibility in both the US and Asia, including roles with Sparton Corporation (Group VP, Manufacturing & Design Services Business Unit; Group VP, Medical Business Unit), SynCardia Systems (COO; VP Operations), Ventana Medical (VP & General Manager, Operations), Robotic Vision Systems, INC (General Manager, Vanguard Division; VP Operations, Systemation Division). He currently serves on the Board of Directors of BioOhio to support and promote Ohio’s bioscience industry. Mr. Gaul has a BS, Business Administration from Delaware Valley University, and an MBA from Florida Institute of Technology.